What is Microcube?
Microcube operates as a vertically integrated medical device developer, distinguishing itself through a self-sufficient, start-to-finish model. The company functions as an innovation hub, concurrently managing multiple high-stakes projects that span the entire product lifecycle—from initial clinical need identification to regulatory approval and market deployment. By housing diverse capabilities such as rapid prototyping, intellectual property management, and clinical trial oversight under one roof, Microcube minimizes friction in the development process. This multidisciplinary approach allows the firm to maintain a high velocity of output, effectively bridging the gap between conceptual design and practical clinical application in a rapidly evolving healthcare market.
How much funding has Microcube raised?
Microcube has raised a total of $359K across 2 funding rounds:
Debt
$150K
Debt
$209K
Debt (2020): $150K with participation from PPP
Debt (2021): $209K led by PPP
Key Investors in Microcube
PPP
Public-Private Partnership
What's next for Microcube?
With the infusion of this latest capital, Microcube is well-positioned to scale its internal R&D capabilities and expand its portfolio of breakthrough medical technologies. The strategic focus will likely shift toward optimizing its turnkey product procedures and deepening its market penetration. As the company continues to mentor a new generation of industry specialists, the current funding trajectory suggests a transition toward broader commercialization and the potential for long-term dominance in the medical device sector. Future growth will be predicated on the firm's ability to maintain its agile, multidisciplinary culture while navigating the complex regulatory requirements inherent in global healthcare markets.
See full Microcube company page
